Argenx
ARGX
#564
Rank
HK$289.86 B
Marketcap
HK$4,848
Share price
-0.48%
Change (1 day)
36.87%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Net assets

Net assets on the balance sheet as of June 2024 : HK$33.15 Billion

According to Argenx 's latest financial reports the company has HK$33.15 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Argenx - Net assets on balance sheet (from 2021 to 2020)

Net assets by year

Year Net assets Change
2022-12-31$HK$21.98 B11.25%
2021-12-31$HK$19.76 B23.8%
2020-12-31$HK$15.96 B55%
2019-12-31$HK$10.29 B86.66%
2018-12-31$HK$5.51 B42.23%
2017-12-31$HK$3.87 B613.57%
2016-12-31$HK$0.54 B57.4%
2015-12-31$HK$0.34 B-39.88%
2014-12-31$HK$0.57 B78.99%
2013-12-31$HK$0.32 B87.99%
2012-12-31$HK$0.17 B-39.33%
2011-12-31$HK$0.28 B165.67%
2010-12-31$HK$0.10 B